Synergistic Effect of 3-Bromopyruvate in Combination with Rapamycin Impacted Neuroblastoma Metabolism by Inhibiting Autophagy

BACKGROUND: Alterations in the cell metabolism, such as enhanced aerobic glycolysis, have been identified as a prominent hallmark of cancer cells. 3-Bromopyruvate (3-BrPA) is a proverbial hexokinase (HK)-II inhibitor, which can inhibit cancer cell energy metabolism. Rapamycin is a new type macrocycl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Lei, Ren, Yang, Lu, Jicheng, Ma, Junzhe, Shen, Xudong, Zhuang, Zhixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605667/
https://www.ncbi.nlm.nih.gov/pubmed/33149623
http://dx.doi.org/10.2147/OTT.S273108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605667/
https://www.ncbi.nlm.nih.gov/pubmed/33149623
http://dx.doi.org/10.2147/OTT.S273108

Ejemplares similares